The Schall Law Firm Has Opened An Inquiry Into Cardlytics Inc. For Securities Fraud And Stakeholders Are Urged To Join

LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cardlytics claimed to the market that its technology initiatives were "really paying off." But the Company's Q2 2024 financial results, released on August 7, 2024, significantly missed its projections from just three months prior. The Company blamed the shortfall on "fast-paced changes to our technology platform." When questions by analysts, the Company's management admitted that its technology issues had been known for "a quarter or two."

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.